Syneos Health, the only fully integrated biopharmaceutical solutions organization, agreed to acquire Illingworth Research Group, a provider of clinical research home health services. Financial terms were not disclosed. "Joining Syneos Health offers significant opportunities to utilize our in-home clinical research expertise at greater scale, with the goal of enabling more patients to participate in trials. Illingworth Research and Syneos Health share complementary therapeutic expertise and cultural philosophies, and we plan to capitalize on our combined teams’ insights and technologies to speed innovation. We look forward to realizing the benefits of this combination for both patients and our employees," John Illingworth, Illingworth Research Group Chairman and Founder.